As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...